论文部分内容阅读
目的:评价克拉霉素分散片联合阿奇霉素治疗重症支原体肺炎的疗效。方法:选取我院2013年10月-2014年10月收治的36例重症支原体肺炎患者,随机分成观察组(18例)与对照组(18例),对照组患者采用阿奇霉素治疗,观察组患者采用克拉霉素分散片+阿奇霉素治疗,对比两组的疗效。结果:观察组的治疗有效率明显高于对照组(P<0.05),不良反应发生率与对照组无明显差异(P>0.05)。结论:使用克拉霉素分散片于阿奇霉素联合治疗重症支原体肺炎疗效确切,能提高治疗效果,减少不良反应。
Objective: To evaluate the efficacy of clarithromycin dispersible tablets combined with azithromycin in the treatment of severe mycoplasma pneumonia. Methods: Thirty-six patients with severe mycoplasma pneumonia admitted from October 2013 to October 2014 in our hospital were randomly divided into observation group (18 cases) and control group (18 cases). Patients in the control group were treated with azithromycin and patients in observation group Clarithromycin dispersible tablets + azithromycin treatment, compared the efficacy of the two groups. Results: The treatment efficiency in the observation group was significantly higher than that in the control group (P <0.05). There was no significant difference in the incidence of adverse reactions between the observation group and the control group (P> 0.05). Conclusion: The use of clarithromycin dispersible tablets in azithromycin combined treatment of severe mycoplasma pneumonia is effective, can improve the therapeutic effect and reduce adverse reactions.